Zinc-ORS in Severe and Complicated Acute Diarrhea
Launched by CENTRE FOR INTERNATIONAL HEALTH · Aug 31, 2006
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Zinc deficiency is prevalent in developing countries due to inadequate food intake, low intake of foods from animal sources and high dietary intake of phytate, a substance that reduces zinc absorption. A recently completed trial at All India Institute Of Medical Sciences (AIIMS) measured the effect of zinc-ORS in the community, where most episodes are relatively mild. Zinc-ORS was efficacious in reducing the total number of stools (19% relative risk reduction, 95% CI 15% to 23%) and duration of diarrhoea (11% relative risk reduction, 95% CI 4% to 24%). In order to make policy decisions that...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males
- * Age 1 month up to 36 months:
- • Passage of 3 or more liquid stools in a 24-hour period, every day, and at least one in 12 hours prior to admission
- • Diarrhea for \< 7days (168 hours)
- Exclusion Criteria:
- • severe systemic illness requiring intensive care management; systemic infection will be suspected if there is a general appearance of non-wellbeing with one or more of the following symptoms: shrill cry and irritability, temperature instability, hypotension, hypoglycemia, altered sensorium, lethargy or refusal of feeds, abdominal distension.
- • chronic illness like Tuberculosis, Nephrotic syndrome, malignancy etc or any surgical disorder.
- • severe malnutrition (weight for age \<65% of NCHS median
- • gross blood in stool
- • refusal of consent
About Centre For International Health
The Centre for International Health is a leading research organization dedicated to advancing global health through innovative clinical trials and interdisciplinary collaboration. With a focus on addressing pressing health challenges in low- and middle-income countries, the Centre employs a comprehensive approach that integrates epidemiology, public health, and health systems research. By partnering with local communities and international stakeholders, the Centre aims to generate robust evidence that informs policy and practice, ultimately improving health outcomes and promoting equity in healthcare access worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, , India
New Delhi, , India
Patients applied
Trial Officials
Shinjini Bhatnagar, PhD, MBBS
Principal Investigator
All India Institute of Medical Sciences
Tor A Strand, MD, PhD
Study Chair
Centre For International Health
Halvor Sommerfelt, MD, PhD
Study Director
Centre For International Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials